The Food and Drug Administration (FDA) gave its final approval for the chemotherapy drug Pemfexy (pemetrexed) after years of legal battles.
Preliminary data from a study done by Targovax show a numerical advantage in Progression-Free Survival in patients treated with ONCOS-102.
Phase II of a clinical trial involving surgery, radiation, and chemotherapy is actively recruiting patients with pleural mesothelioma.
A good night's sleep is essential for mesothelioma patients. Here's why.
Certain foods, supplements, and herbal products can interact with cancer medications and may increase the risk for serious side effects.
Each year, members of the medical community, non-profits, and patient organizations join forces to bring lung cancer back into the public eye.
A non-invasive treatment that combines chemotherapy with electrical currents to shrink mesothelioma tumors appears to be working for a group of patients.
Eating a healthy diet is important for cancer patients to maintain proper nutrition. There are 5 simple ways mesothelioma patients can improve diet.
Phase II of a clinical trial is recruiting mesothelioma patients to test the effectiveness of two immunotherapy medications in combination.
The results of a recent Phase 3 clinical trial have led to a disappointing setback for the mesothelioma community.